Tools
Tools
Engels, Dirk, Hotez, Peter J, Ducker, Camilla, Gyapong, Margaret, Bustinduy, Amaya L, Secor, William E, Harrison, Wendy, Theobald, Sally 
ORCID: https://orcid.org/0000-0002-9053-211X, Thomson, Rachael, Gamba, Victoria, Masong, Makia C, Lammie, Patrick, Govender, Kreeneshi, Mbabazi, Pamela S and Malecela, Mwelecele N
(2020)
'Integration of prevention and control measures for female genital
schistosomiasis, HIV and cervical cancer'. Bulletin of the World Health Organization, Vol 98, Issue 9, pp. 615-624.
|
Text
20-252270 Sally Theobald.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Female genital schistosomiasis as a result of chronic infection with Schistosoma haematobium (commonly known as bilharzia) continues to be largely ignored by national and global health policy-makers. International attention for large-scale action against the disease focuses on whether it is a risk factor for the transmission of human immunodeficiency virus (HIV). Yet female genital schistosomiasis itself is linked to pain, bleeding and sub- or infertility, leading to social stigma, and is a common issue for women in schistosomiasis-endemic areas in sub-Saharan Africa. The disease should therefore be recognized as another component of a comprehensive health and human rights agenda for women and girls in Africa, alongside HIV and cervical cancer. Each of these three diseases has a targeted and proven preventive intervention: antiretroviral therapy and pre-exposure prophylaxis for HIV; human papilloma virus vaccine for cervical cancer; and praziquantel treatment for female genital schistosomiasis. We discuss how female genital schistosomiasis control can be integrated with HIV and cervical cancer care. Such a programme will be part of a broader framework of sexual and reproductive health and rights, women’s empowerment and social justice in Africa. Integrated approaches that join up multiple public health programmes have the potential to expand or create opportunities to reach more girls and women throughout their life course. We outline a pragmatic operational research agenda that has the potential to optimize joint implementation of a package of measures responding to the specific needs of girls and women
| Item Type: | Article |
|---|---|
| Subjects: | WA Public Health > Health Problems of Special Population Groups > WA 309 Women's health WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503 Acquired immunodeficiency syndrome. HIV infections WC Communicable Diseases > Tropical and Parasitic Diseases > WC 810 Schistosomiasis WP Gynecology > Anatomy. Diseases. Injuries > WP 400 General works |
| Faculty: Department: | Biological Sciences > Department of Tropical Disease Biology Clinical Sciences & International Health > International Public Health Department |
| Digital Object Identifer (DOI): | https://doi.org/10.2471/BLT.20.252270 |
| Depositing User: | Tina Bowers |
| Date Deposited: | 01 Oct 2020 17:25 |
| Last Modified: | 11 Nov 2020 12:03 |
| URI: | https://archive.lstmed.ac.uk/id/eprint/15693 |
Statistics
Actions (login required)
 |
Edit Item |